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Abstract
Modern threats of bioterrorism force the need to develop methods for rapid and accurate identification of dangerous 
biological agents. Currently, there are many types of methods used in this field of studies that are based on immunological 
or genetic techniques, or constitute a combination of both methods (immuno-genetic). There are also methods that have 
been developed on the basis of physical and chemical properties of the analytes. Each group of these analytical assays can 
be further divided into conventional methods (e.g. simple antigen-antibody reactions, classical PCR, real-time PCR), and 
modern technologies (e.g. microarray technology, aptamers, phosphors, etc.). Nanodiagnostics constitute another group 
of methods that utilize the objects at a nanoscale (below 100 nm). There are also integrated and automated diagnostic 
systems, which combine different methods and allow simultaneous sampling, extraction of genetic material and detection 
and identification of the analyte using genetic, as well as immunological techniques.
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INTRODUCTION
Increasing threats of bioterrorist attacks have forced the need 
to develop methods for rapid detection and identification 
of biological agents. These types of analyses are important 
not only to confirm the fact of a bioterrorist act, but also 
to choose the most effective methods of protecting public 
health [1, 2, 3]. To detect and identify biological agents, 
a number of technologies have been developed, some of 
which were available before September 11, 2001, and 
others were introduced later [4]. Although it is claimed 
that many of the technologies satisfy the criteria of speed, 
accuracy and reliability, only a few of them can be used in 
the field [4].
Bioterrorism, as well as natural biological contaminations, 
present many challenges for diagnostic methods. Some of 
them are designed to detect the attack, while others may 
be suitable for different kinds of needs (including clinical). 
Diagnostic methods should provide the possibility of 
detection and confirmation of biological risk factors, 
including modified and unknown factors, directly from 
the sample, without false positive and false negative results. 
The devices for detection should be portable, easy to use 
and capable of detecting a number of factors simultaneously 
[4]. Although several diagnostic methods satisfy many of 
these criteria, none satisfy all of them. Diagnostic assays 
must be sensitive and specific, without interference from 
other materials. In contrast to chemical detectors that 
detect chemical agents in amounts threatening to human 
health, biological detectors can rarely detect microorganisms 
directly from samples at or below the risk levels, because of 
their low sensitivity. Diagnostic systems based on the nucleic 
acid amplification methods are more sensitive than systems 
based on the use of antibodies [4]. The PCR method enables 
detection of a single microorganism in a short period of time 
[5, 6, 7]. However, the PCR technique requires a clean sample 
and does not allow to the detection of toxins and particles 
that do not contain nucleic acids, such as prions [4]. The PCR 
products cannot be stored and undergo further analysis. 
In addition to sensitivity, specificity of the methods is also 
important to minimize background signals and to eliminate 
false-positive results with samples that are often a complex 
mixture of organic and inorganic compounds. Specificity can 
be determined not only by interfering substances, but also by 
high concentrations of competing antigens or DNA. In the 
case of PCR, the high sensitivity can also be weak because 
of the possibility of DNA- contaminated amplification and 
obtaining false positive results. In addition to sensitivity and 
specificity, reproducibility is another important imposed 
requirement of diagnostic methods. A number of factors can 
affect the reproducibility of the methods, including stability 
and consistency of reagents and the differences in assay 
conditions. These differences can be reduced by standardizing 
the assay conditions and procedures. Diagnostic methods 
must provide the ability to detect different biological agents 
in samples. This is necessary because the investigated samples 
can contain toxins, bacteria, viruses, or other types of 
compounds. In some cases, unknown biological factors may 
have been deliberately altered through genetic, antigenic or 
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chemical modifications, or may represent new or previously 
unknown variants of known microorganisms, which makes 
the detection of biological agents extremely difficult. Even 
without modification, the conventional biological agents are 
difficult to detect in contaminated samples. Human samples 
(e.g. blood and faeces), as well as powders, food, water, 
and even air, present challenges for diagnostic methods. 
Anticoagulants, leukocyte DNA and heme compounds 
inhibit the PCR reaction [8, 9]. Fats in ground beef and a 
large number of accompanying bacteria in faecal samples 
may interfere with immunological assays. For this reason, 
biological agents must be isolated or purified from the 
samples prior to analysis and identification, which increases 
the time of analysis and, importantly, makes it impossible 
to apply in the field. Some of the viable organisms cannot 
be grown rapidly (e.g. Francisella tularensis, Mycobacterium 
tuberculosis) or have specific nutritional requirements. An 
important factor in biodetection is the type of material, the 
procedure of sample storage and transport. Samples derived 
from the water and air must be concentrated prior detection 
of the target factor. Air samples must be carried out in a liquid 
state because the majority of diagnostic methods are adapted 
only to liquid samples. The efficiency of recovery of the target 
analyte can change and affect the detection limit. The size, 
number and distribution of the sample, as well as time and 
method of transport is also an important factor, particularly 
in relation to viable organisms. In some cases, confirmation 
of microbe viability may be important to determine whether 
it poses a health risk (PCR method does not provide such an 
answer, with the exception of mRNA) [4].
Various methods for detection and identification of 
pathogens have been used for many years [4]. They are 
based on culture and biochemical tests. Although they are 
valuable, they cannot be used in the field, and in the event 
of a bioterrorist attack they do not allow detection and 
identification of biological agents in real time. Many financial 
resources have been currently invested in the development 
of commercial technologies that can rapidly and accurately 
detect and identify biological agents, both in the field, as well 
as in stationary laboratory conditions [4].
Immunological methods. Immunological tests, since their 
emergence, have been constantly improved to provide a 
useful tool for the detection of infectious diseases, drugs, 
toxins and pollutants in the medical, pharmaceutical and 
food industry. In addition, immunological detection has been 
successfully used to detect bacterial cells, spores, viruses and 
toxins, considering the fact that each component, which is 
able to elicit an immune response, can be used as antigen. 
Various types of immunoassays used to detect biological 
agents have been described [4, 10]. Typically, they can analyze 
only one factor in the sample, which means that to detect 
more than one microorganism in a sample it is necessary to 
perform many simultaneous or successive tests. Elaboration 
of assays that would enable simultaneous detection of multiple 
targets is still a subject of investigation [4]. The specificity 
of immunoassays is limited by the quality of antibodies, 
and their sensitivity (detection limit of ~105 CFU). Thus, 
it is generally lower than PCR and other assays based on 
DNA amplification. Improving the quality of antibodies (e.g. 
production of antibodies from recombinant libraries) and the 
conditions of the applied tests may increase the sensitivity 
and specificity of immunoassays [4].
Many different immunoassays are currently commercially 
available. Some of them are enzyme-linked immunosorbent 
assays (ELISA) that belong to the type of classic sandwich 
assays [4]. These assays can be performed with various 
substrates and labels (fluorescent, chemiluminescent and 
electrochemiluminescent), as well as on many types of 
platforms (biosensors, flow cytometry, microarrays and 
lateral flow devices).
In Luminex xMAP technology the basic sandwich assay 
format has been used: antibodies are coated on the surface 
of polystyrene beads instead of a plate, and the beads are 
then separated by flow cytometry [11]. Since each type of 
bead may be coated with a different set of antibodies, it is 
possible to perform multiple tests simultaneously. The beads 
are kept in solution during the process of binding the target 
antigen to the specific antibody, and the spectral dual laser 
system is used for detection. The laser detects excitation of 
the donor and acceptor dye of each bound antigen, wherein 
the signal intensity is proportional to the amount of antigen 
present in the sample. xMAP technology is a part of ongoing 
environmental monitoring systems [12] and has been used to 
assess human exposure to dangerous biological agents [13].
Immunoprecipitation technique. A technique based 
on paramagnetic bead technology applied by Bertin 
Technologies in a KIM device. This small ruggedized 
device was developed as a field unit for on-site confirmation 
of the presence of bio-warfare agents in a hot-zone. The 
performance characteristics of this equipment are very 
promising, even better when compared with ELISA and 
immune HHA. The device is designed to work together with 
a stand-alone bio-aerosol detector and Coriolis air sampler. 
Man-operated immunodetection confirms or excludes tested 
bio-warfare agents. A serious disadvantage of KIM is the 
current ‘under development’ status of this instrument, and 
limited availability of the agent-specific tests.
The BV M-series device uses electrochemiluminescence 
to detect reporter molecules used in the sandwich assay. In 
BV assays, paramagnetic beads are used as carriers of the 
antibodies [14]. After binding of the antigen to the reporter 
antibodies labeled with BV-TAG, Ru(bpy)3
2+, the bound 
antigens pass through the flow cytometer and are captured 
by the magnet on the electrode surface, leading to their 
separation from other components. The electrical potential 
generated by the electrode excites BV-TAG (ruthenium (II), 
tris-bipyridine, N-hydroxysuccimid), which then emits light 
that is recorded by the detector. This technology is mainly 
used for clinical purposes, and also to detect, e.g. Escherichia 
coli O157 [15, 16, 17], Bacillus spores [16], Yersinia spp. [16], 
Salmonella enterica serovar Typhimurium [17] and toxins [18].
Bio-Detector, based on the ELISA assay tape system is a 
stable, portable package. Liquid samples are injected and 
separated, and each sample mixed during the reaction with 
fluorescein- and biotin-streptavidin-labeled antibodies, 
which bind to biotin. After binding of labeled antibody to 
the antigen they are filtered, and then captured by a tape 
coated with biotin, located in different positions to each 
sample. Streptavidin acts as a bridge between the biotin-
labeled antigen and biotin-coated tape. Anti-fluorescein 
antibody solution, conjugated with the enzyme urease is 
filtered through the tape and binds captured antigen. In 
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the next step, the tape is placed over the sensor and coated 
with an urea solution. If the tape has bound antigen, urease 
hydrolysis the urea, causing a change in pH in correlation 
with the amount of target antigen. The sensor processes the 
signal, so that the data on the presence and amount of antigen 
present in the sample are obtained [4].
DELFIA system (dissociation-enhanced lanthanide 
fluorescence immunoassay) is an example of the format based 
on time-resolved fluorescence. This technique is based on the 
labels that are the complex lanthanide compounds, which 
have long fluorescence decay times, allowing measurements 
of fluorescence without interference from background 
signals. Typically, the assays are performed on a standard 
ELISA microplates (detected antibodies are labeled with 
lanthanides) and the label dissociates from the antibodies 
following the incubation, using a low pH solution. Free 
molecules form a new, stable chelates of high fluorescence 
intensity, recorded by the system. The DELFIA system is 
used, e.g. for detection of Francisella tularensis, Clostridium 
botulinum toxins and staphylococcal enterotoxin B [10].
Lateral flow devices have been developed primarily for 
rapid field diagnostics, but can also be useful for clinical 
laboratories. These are single-use assays, based on 
immunochromatographics or enzymatic assays, giving 
visible, coloured end products that confirm or exclude the 
presence of the factor. The system is based on the antibodies 
coated on cellulose or membrane, and uses capillary flow 
forces for the elution of antigens labeled with colloidal gold, 
or coloured microparticles conjugated with antibodies in 
the liquid phase. Positive result is achieved by binding of the 
labeled antigen-antibody complex with a second, immobile 
antibody (usually directed against immunoglobulin G) [4]. 
Negative result (control) is an indicator of the accuracy of 
the assay and passing the sample through the field test. 
Although this type of assays are easy to perform and fast, 
they are not too sensitive and give more false positive results. 
However, they may be useful for rapid initial screening of 
samples for the presence of biological agents, although, as 
a matter of principle, any positive result must be confirmed 
by other tests, such as PCR. Lateral flow devices have been 
developed by many companies for such biological agents 
as Bacillus anthracis, Francisella tularensis, Yersinia pestis, 
Clostridium botulinum and several toxins, such as ricin and 
staphylococcal enterotoxin B [4].
Immunological techniques usually use both conventional 
antibodies, as well as other forms of antibodies, including 
mono- and bivalent antibody fragments, such as Fab’ and 
F(ab’)2 and single-chain variable regions, which were tested 
for their sensitivity, specificity and stability [19, 20, 21, 22]. 
These fragments can also be modified using recombination 
for improving the binding kinetics of antigen-antibody 
fragments [21]. Phage libraries allow increasing the affinity 
of antibodies by selecting from the thousands of possible 
peptides, one that shows the highest binding efficiency to the 
antigen. The selected antibodies or their fragments can be 
subsequently synthesized chemically or produced in a large 
amount in a recombinant host [21]. The antibodies or their 
fragments, being the products of phage expression, can also 
be used [21]. Using this methodology, the antibodies binding 
bacteria, e.g. Brucella melitensis [23], viruses, such as vaccinia 
virus [24], and toxins, e.g. Clostridium difficile toxin B [25] 
and botulinum toxin [19], have been produced. The final 
expression products can be isolated or remain associated 
with the phage [21, 23, 25].
The use of aptamers and peptide ligands constitutes 
an alternative to antibodies. Aptamers are small DNA or 
RNA ligands formed using combinatorial methods, which 
recognize antigen on the basis of the sequence, not a spatial 
structure. Aptamers are used, for example, for the detection 
of ricin by the biochip bead sensor [26] and cholera toxin, 
staphylococcal enterotoxin B and Bacillus anthracis spores 
in the electrochemiluminescence assay [27]. It was found 
that ribozymes and autocatalytic RNA can generate a 
signal after binding antigen [28] and photoaptamers, and 
DNA aptamers bind antigen under UV light influence [29]. 
In short, recombinant peptide sequences are also tested 
for their binding and detection ability in biosensors. As 
phage-produced antibodies or their fragments, they can 
be chemically synthesized. Reports have been published 
on the use of synthetic sequences specifically binding ricin 
[30], Bacillus anthracis spores and other Bacillus species 
[31, 32,  33], Staphylococcus aureus protein A [34] and 
staphylococcal enterotoxin B [35].
Biochip technology. Methods for detecting antigens using 
biochip technology have been described recently [36]. One 
of latest uses dielectrophoresis for the concentration of 
antigens, followed by immunoelectrophoretical detection 
[37, 38]. The combination of immunoelectrophoresis and 
dielectrophoresis enables targeting of assay components 
and antigens in the appropriate position, and reading of the 
results is performed by fluorescence microscopy. This method 
was applied to detect Escherichia coli O157: H7 and Bacillus 
globigii spores [38], staphylococcal enterotoxin B and cholera 
toxin B [38]. In the second variant, the system uses sensors 
on a chip of metal oxide semiconductors for the detection of 
antigens on the microarray [39]. All points on the microarray 
can be analyzed simultaneously or separately by optical 
detectors. This technology has been developed to detect 
Bacillus globigii spores in the air, which was possible through 
the integration of a portable air sampler with on-chip ELISA 
[40]. A similar system has also been used in the microarray 
immunoassay in which oligonucleotides-labeled antibodies 
were introduced on the chip and bound with complementary 
nucleotides in the matrix [41, 42]. This system has been used 
to detect ricin, M13 phage and Bacillus globigii spores, and 
drugs. The lab-on-a-chip technology has also been developed 
for rapid detection of botulinum toxins [43].
Contemporary research on new methods of antigens 
detection have drawn attention to the usefulness of biosensors 
based on the phenomenon of surface plasmon resonance. This 
type of sensors detect antigens directly by measuring changes 
in the refractive index which occur at the time of binding 
antigen with the surface coated with a metal (mainly gold or 
silver) [44]. Commercial devices are now big, but miniature 
versions have been developed, suitable for the detection of, e.g. 
staphylococcal enterotoxin B under field conditions [45, 46]. 
The miniature gold-coated sensor uses peptides bound with 
the metal surface to target the specific antigen, and to monitor 
the angle of reflection at different wavelengths, leading to 
signal generation. It is temperature-controlled and has two 
channels, one of which serves as a control channel. Another 
miniature surface plasmon resonance device uses a polished, 
single optical fibre to monitor spectral changes of different 
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angles of incidence [47]. Such device has been used, e.g. for 
direct detection of staphylococcal enterotoxin B in milk 
[47]. The sensitivity of the assay has been increased by signal 
amplification using a secondary antibody [48].
Surface plasmon resonance is a physical phenomenon, 
applied for the first time by Genoptics in a set of SPRi devices 
which served for immunodetection. This instrument may be 
used for continuous flow monitoring of liquefied samples (e.g. 
when combined with any aerosol –liquids samplers). Due 
to lack of any markers and reversibility of antibody-antigen 
reaction, SPRi allows for low running costs and performance 
characteristics comparable to ELISA techniques. Another 
advantage is the high multiplexing capability of this 
technology. However, it may take some more time to develop 
an instrument with a set of ready-to-use assays for biodefence 
applications.
Another method using biosensors is based on the excitation 
by evanescent wave of fluorophores-labeled antibodies bound 
to antigens on the waveguide surface [44, 49]. Several such 
devices have been studied for their ability to detect biological 
agents. One of the introduced instruments – RAPTOR, uses 
antibodies coated on the polystyrene fibre optic waveguides. 
The samples pass through the waveguides, and the antigens are 
bound by the antibody, following binding fluorophore-labeled 
antibodies on the waveguides. Fluorophore molecules, whose 
size ranges from 100 – 1,000 nm, are excited on the waveguide 
surface by the evanescent range of laser light. Next, part of the 
emitted energy joins to the optical fibre and is measured and 
quantified by the photodiode. The increase of fluorescence is 
proportional to the concentration of antigen. The RAPTOR 
biosensor, and its predecessor Analyte 2000, has been used 
directly to detect biological agents in a variety of environmental 
materials, including food [4, 50], river water containing 
organic compounds and microorganisms [51], powders [52] 
and clinical samples [53, 54, 55]. An array biosensor, and 
biosensor of integrated waveguide have also been developed. 
In the array biosensor, the antigens are bound by the antibody 
on a slide. Fluorescently-labeled native antibodies are added 
and the views recorded by a camera after excitation by a laser 
[56, 57]. The array biosensor has been used to detect antigens 
in a variety of complex materials, including toxins in body 
fluids, environmental samples and food [56], and bacteria 
in food [57]. In the integrated waveguide biosensor the glass 
capillary tubes are used as waveguides, so that staphylococcal 
enterotoxin B can be detected at a level of pg/ml [56].
Cantilever technology uses mass changes to detect antigens 
bound on the surface of the device. Antigenic specificity 
is achieved by adsorption or binding of certain types of 
molecules to the substrate surface, which increases the 
mass and changes the frequency of support. The cantilever 
biosensor has been used to detect Escherichia coli O157: H7 
in a suspension containing 106 to 109 cells/ml [4].
Magneto-elastic cantilever immunosensor which uses 
magnetic fields to induce sensor vibration has been also 
developed [58]. In this case, the sensor surface is coated with 
antibodies which specifically bind to target antigens. The 
binding of antigen-alkaline phosphatase-labeled antibodies 
causes signal amplification by increasing the total mass of the 
sensor. This sensor has been studied with regard to detection 
of the presence of Escherichia coli O157: H7 and staphylococcal 
enterotoxin B, with a sensitivity of 102 cells/ml and 
0.5 ng/ml respectively. Another tested possibility to improve 
the detection of Salmonella enterica serovar Typhimurium 
uses impedance analysis of a quartz crystal oscillator, which 
constitutes the basis for the piezoelectric biosensor [59]. 
Antibodies coated on paramagnetic microspheres provide 
the specificity and increased reactivity of the sensor. The 
detection limit is reported to be 103 cells/ml.
The next device, which has been tested to study Bacillus 
thuringiensis spores as surrogates of Bacillus anthracis spores, 
is based on surface acoustic wave technology [60]. The use of 
a horizontal cut wave allows the acoustic measurements in a 
liquid environment, and the surface coated with monoclonal 
antibodies provides a specific binding of the antigen. The 
ability to detect inhaled Bacillus thuringiensis spores at, or 
below the threshold dose for Bacillus anthracis infection has 
been indicated.
Nowadays the up-converting phosphors technology is 
beginning to replace the fluorescent dyes through the use 
of unique, submicroscopic ceramic particles containing a 
rare-earth element [61, 62]. These labels absorb more than 
one low energy photon (IR) in order to achieve a higher 
energy state, emitted as phosphorescence when the crystal 
returns to the ground state. Since this process does not occur 
naturally, it is possible to eliminate background signals using 
such labels. Hampl et al. [61] described a method of binding 
the up-converting phosphors with antibodies, and used them 
both in lateral flow assays, and plate assays for the detection 
of human chorionic gonadotropin and for simultaneous 
detection of gonadotropin and albumin. Niedbala et al. [62] 
applied this technology in the sandwich assay with a side flow, 
reaching the sensitivity of 103 CFU/mL Escherichia coli O157: 
H7 in an enriched medium containing 109 organisms/ml, 
grown from infected ground beef. This enriched medium 
served as a negative control background in the assay. The 
usefulness of this technology has also been studied in the 
assays based on nucleic acid amplification [63].
MesoScale technology, principally based on the same 
immunodetection phase as BioVeris, uses a dry plate instead 
of beads. Eletro-chemiluminescence of ruthenium complex 
provides greater sensitivity. Since BioVeris was merged with 
the Roche Corporation in 2007, it discontinued ECL for 
application in the defence against biothreats. MesoScale 
launched instruments PR 2 1500, 1800 and 1900, as well as set 
assays related to defence application. These ruggedized models 
offer full automatisation of sample processing, or aerosol 
sampling with its processing, as well as high-throughput 
capability. The methods based on the MesoScale technology 
are able to confirm the presence of almost a full spectrum 
of biowarfare agents with ‘ready-to-use’ kits provided by the 
producer (including B. anthracis, F. tularensis, Y. pestis, C. 
botulinum, Escherichia coli O157, Brucella, Orthopox, VEE 
and some toxins). However, the availability of this technology 
is limited to the USA, which is a serious disadvantage for 
European users.
Genetic methods. Detection methods based on nucleic acid 
amplification use the principal of base pair complementarity 
to detect and identify biological agents [4, 64, 65]. Although 
any biological agent which contains DNA or RNA can be 
detected using these methods [66], their disadvantage is 
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caused by the inability to detect proteins, such as toxins 
and bioregulators [4]. Many assays which were developed on 
the basis of these molecular techniques have been recently 
described [67, 68, 69, 70]. Some of the modern methods 
use isothermal amplification of nucleic acids or enable 
detection of the agent directly from the sample, without the 
amplification step [4].
Quantitative real-time PCR (Q-PCR) combines PCR 
amplification with simultaneous detection of amplification 
products, based on changes in fluorescence intensity, 
proportional to the increase of the product [71, 72]. There 
are two variants of Q-PCR, with specific and non-specific 
detection. The non-specific detection uses DNA-intercalating 
dyes that emit fluoresce when bound to DNA (e.g. SYBR 
Green). During DNA amplification, the dye intercalates 
into the reaction product, following the analysis of the 
melting curve (which provide specificity), whereas during 
the process of DNA dissociation the fluorescence signal 
decreases. This variant is useful for optimization of PCR 
conditions and verification of the specificity of primers. It 
is also less expensive in comparison to specific detection. In 
the latter, change of fluorescence intensity occurs due to the 
use of fluorogenic labeled probes, containing both fluorescent 
dye and sometimes a quencher. The increase of fluorescence 
indicates the hybridization of probes to the target DNA.
Q-PCR has many applications [4]. Many companies offer 
a wide range of combinations of primers and probes in 
various configurations, including TaqMan probes (double-
labeled) [73], with black hole quenchers [74], lock-type probes 
[4], molecular beacons [75], lux-type (fluorogenic labeled 
primers) [76], Hyb-probes (FRET – fluorescence resonance 
energy transfer probes) and scorpion-type probes [77]. Each 
of these types has a different mechanism of monitoring 
the amplification process (e.g. separation of fluorophore 
from the quencher). As the fluorescent dyes attached to the 
primers and probes may have different ranges of excitation 
/emission, Q-PCR can be used for detection of several factors 
simultaneously. These dyes include: 6-carboxyfluorescein, 
6-carboxytetrametylorhodamine, Cy5, Cy3, Rox, Texas Red, 
rhodamine, fluorescein and Oregon Green.
Although the quenchers have the ability to quench the 
entire spectrum of their emission, the optimal solution 
is to match their maximum absorption to the maximum 
dye emission. As technology advances, the instruments for 
Q-PCR are becoming smaller, faster and more sensitive, which 
is important for the rapid identification of biological agents. 
Accurate characterization and identification of bacteria by 
Q-PCR is limited by the efficiency of nucleic acids isolation or 
cell lysis, nucleic acid degradation by nucleases, the primers 
and probes reactivity (i.e. specificity and quantity), as well as 
the variability of the polymerases, buffer and thermocycler 
performance. The efficiency of DNA isolation or cell/spore 
lysis significantly affect the sensitivity, reproducibility and 
accuracy of each PCR method. In addition, the presence 
of inhibitors such as humic acids or chelating agents may 
interfere with probes’ and primers’ targets, resulting in 
obtaining false negative results. Despite these limitations, 
the analyses based on PCR are highly specific and sensitive 
in relation to the selected agent (usually detect 10 – 100 cells).
Automatic real-time thermocycler can quickly analyze 
four samples simultaneously and has brought an interesting 
solution in this area of research [78]. It has been successfully 
used for the detection of Bacillus anthracis from swabs taken 
after the last case of bioterrorism in the USA, and Escherichia 
coli in water samples. SYBR Green dye has been used for 
labeling, enabling positive results to be obtained within 13 – 
32 min. It has been reported that Erwinia herbicola nocturnal 
culture was detected using a TaqMan probe in approximately 
7 min. at a concentration with 500 cells.
NASBA technique is based on the isothermal amplification 
of single-stranded RNA to identify the target organisms. In 
this method, the primer binds to the RNA target sequence, 
and reverse transcriptase produces a cDNA strand. RN-ase 
digests the RNA, and next a second primer binds to the 
cDNA, which is used by reverse transcriptase to synthesize 
a double-stranded cDNA. In the following step, T7 RNA 
polymerase is used to synthesize RNA transcripts during 
the amplification process. This method has been applied 
to detect certain viruses [79, 80, 81, 82], bacteria [83], fungi 
[84] and protozoa [85]. Positive results of the detection of 
microorganisms have been obtained in both environmental 
[81, 83] and clinical samples [80, 81, 84, 85], which indicates 
that NASBA is a sensitive, specific and rapid analytical 
method which can also be used to detect viable organisms 
using mRNA as a template.
Isothermal loop-amplification is a method of DNA 
amplification using the new, displaced strand [86]. In this 
technique, the polymerase and four primers, specifically 
designed to the sequence of both sense and nonsense strands 
of target DNA, are used. This method has been used to detect 
some viruses, such as West Nile virus, Newcastle disease 
virus, influenza A virus, acute respiratory distress syndrome 
virus [87, 88]; bacteria, such as Mycobacterium avium subsp. 
paratuberculosis, Yersinia pseudotuberculosis, Streptococcus 
pneumoniae, Shigella and enteroinvasive Escherichia coli [89, 
90, 91, 92, 93]; and fungi, such as Paracoccidioides brasilliensis 
[94]. It is also useful in the studies of clinical samples [88, 
91, 93, 95]. The technique of identifying bacteria using 
rRNA for Escherichia coli in a mixture containing Bordetella 
bronchiseptica has been described by Maruyama et al.[92]. 
After binding of bacterial rRNA by a single-stranded DNA on 
monolayer, the bacteria were conjugated with another single-
stranded, fluorescein-labeled DNA probe. In the next step, 
the peroxidase-labeled antifluorescein antibodies were used 
to obtain an amplified signal, measured amperometrically. 
The sensitivity of the method was approximately 103 cells of 
Escherichia coli/ml. Further studies based on this approach 
have led to development of a highly specific electronic sensor 
that detects mRNA at concentrations below 1 femtomol [96].
Another approach based on PCR technique, which 
serves to detect biological agents, uses an advanced micro-
electrokinetic system. It applies platforms of universal nucleic 
acid amplification test (NAAT) to identify conserved and 
variable sequences of all human pathogens [97].
DNA-selective fluorescent dye is a novel technology that 
has been used in the Prime Alert system for detection of all 
bacteria and spores, as well as many viruses by LATE PCR 
(Linear After the Expotential Polymerase Chain Reaction). 
This system can also detect toxins, such as ricin, botulinum 
toxin A and B or staphylococcal enterotoxin B, using FT-IR 
(Fourier-Transform Infrared Spectroscopy).
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PCR technique can also be combined with other diagnostic 
methods, such as mass spectrometry. PLEX-ID technology 
allows for rapid identification of microorganisms (bacteria, 
viruses, fungi, certain parasites) with the possibility of 
genotyping. PLEX-ID system is designated rather for use 
in stationary laboratories. All steps related to nucleic acid 
isolation and PCR products amplification may be carried out 
manually or on automated devices. PCR reaction (multiplexed 
or not) results in the synthesis of a number of amplicons 
for each sample (depending on the general panel used), 
which correspond to selected regions of the genome agent 
(e.g. 16SrRNA region, species specific region). Subsequent 
electrospray ionization and time-of-flight mass spectrometry 
allows for very accurate determination of molecular size and 
weight of both strands of each product. Thanks to a very 
broad and comprehensive molecular database, the obtained 
results for each product, analyzed by comparison with the 
available referees base, may lead to unique identification 
of the sample. The entire procedure, including PCR, lasts 
about eight hours. There are a number of detection panels 
available now in this technology (respiratory virus, bio-
threat, broad bacteria, broad viruses, food borne, multi-drug 
resistance, among others). The advantages of such technology 
include extremely high multiplexing capability (up to 1,000s 
of agents) and significant throughput. These features make 
PLEX-ID an excellent device in the case of analyzing samples 
of unknown origin. On the other hand, the initial investment 
price may be a serious disadvantage for wider use of PLEX-ID.
Biochip technology has also been applied for the detection of 
nucleic acids [4, 57, 98, 99, 100, 101, 102, 103]. One of the more 
investigated methods is the electric-field-driven method for 
immunological detection of bacterial DNA. Here, the bacteria 
concentrated by dielectrophoresis are lysed, and the obtained 
DNA is denatured at high temperature, following duplication 
by the displaced-strand amplification [38, 100] and analysis 
using the ‘on-chip’ electric-field-driven hybridization assay. 
This assay has been used, e.g. to distinguish six gene sequences 
of different bacteria, such as Escherichia coli, Salmonella, 
Campylobacter, Staphylococcus, Chlamydia [100].
Ali et al. described the use of another chip technology, 
based on the detection of antibodies, and proved its 
suitability for the detection of amplified DNA using capillary 
electrophoresis and laser-induced fluorescence [102]. The 
DNA of enterotoxic strain Escherichia coli was used in this 
assay, demonstrating that this method was comparable 
with the gel analysis of PCR in terms of identification of 
specific amplicons; it was faster and created the possibility 
of multiplexing on microarray platform.
For rapid distinction of a mixture of similar 18-nucleotide 
DNA fragments, ‘taste chip’ technology was also used, applying 
antibody-based biochips [102], in which microspheres coated 
with DNA probes were placed in micro-cavities on a silicon 
chip, through which the samples containing the target DNA 
were passed. This allowed for rapid identification of a single 
nucleotide mismatch, obtaining the limit detection level of 
approximately 10–13 M.
These techniques can also be used to detect bacterial cells, 
which was demonstrated on the example of Escherichia coli 
K-12 [103]. The analysis steps using this biochip included 
sample binding, preparation, PCR, hybridization, and 
electrochemical detection. The sensitivity of the method 
was 103 cells with a very low background level.
Other genetic methods are applied for forensic and 
phylogenetic studies. They include analysis of variable 
number tandem repeats (VNTR) [104], multi-spacer 
sequence typing (MST), multilocus-sequence typing (MLST), 
pulsed field gel electrophoresis (PFGE), restriction fragment 
length polymorphism (RFLP), amplified fragment length 
polymorphism (AFLP), and nucleic acid sequencing. These 
genotyping methods give the ability to detect new, mutated 
strains of these bacteria.
Other diagnostic methods. Among the known detection 
systems there are also devices which use a response of specific 
cell types to toxic or infectious agents in order to identify 
them. In these devices, the cells constituting the sensor 
generate a signal which can be measured by an electrode or 
an optical detector. The detector cells may originate from 
specific single-cells organisms or tissues, such as nerve tissue 
or heart cells, and may be in both a primary and settled 
state [4].
The search for a different, improved type of cell biosensor 
based on B cells, is being continued. The role of B cells is to 
present the surface antibodies which serve as a receptors 
for various pathogens. Rider et al. [105] designed B cells 
capable of expressing aequorin and jellyfish protein that 
emits radiation due to the calcium ions flow and pathogen-
specific surface antibodies. Although this type of cell 
biosensor provides high specificity, the problem of cross-
reactivity of antibodies may arise. For the detection of 
biological agents, the chromatophores – colourful cells 
found in skin of cold-blooded animals – were also applied 
[106]. Chromatophores are responsible for pigmentation and 
masking in these animals and change colour on exposure 
to various biologically-active substances, such as pesticides, 
neurotransmitters and bacterial toxins. The colour change 
can be observed microscopically or spectrophotometrically. A 
biosensor that uses fish chromatophores has been developed. 
It has been examined with regard to its detection capability of 
both chemical and bacterial toxins, obtaining, e.g. the limit 
detection level of Bacillus cereus below the EPA standard [105, 
106]. Since the fish chromatophores multiply very weakly, 
there is no need for frequent exchange of culture medium 
in this method.
Biosensors based on physical and chemical properties react 
to the characteristic features of the target analyte. Examples 
of these technologies include: mass spectrometry, Raman 
spectrometry and intrinsic fluorescence/luminescence. 
These methods do not require additional biological reagents; 
however, they may use the affinity of probes to increase the 
binding capacity and specificity. Use of the spectroscopic 
method in various wavelength UV/Vis, which utilizes both 
light scattering and absorbing properties of vegetative cells 
and spores, has also been studied [107]. The obtained data 
indicate that it is possible to differentiate vegetative cells 
of different bacteria species and to distinguish vegetative 
bacteria cells from spores, while the disadvantage is the 
need for thorough sample preparation in order to obtain a 
pure suspension of the material in non-absorbing medium.
There have been also many attempts to develop a biosensor 
based on mass spectrometry [108, 109], in which the sample 
components are identified on the basis of molecular weight 
analysis. This type of device has been used to identify 
bacterial and viral proteins [110] and bacterial cells [111], 
and also to distinguish Bacillus thuringiensis and Bacillus 
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atrophaeus spores in spray [112]. Most of these methods 
use a matrix-assisted laser desorption /ionization time-
of-flight (MALDI-TOF). The systems are fast and do not 
require the use of additional reagents. Moreover, a small 
volume of samples is sufficient for the analysis. MALDI-TOF 
/mass spectrometry is theoretically capable of identifying 
all types of biological agents, including viruses, bacteria, 
fungi and spores. The disadvantage of this method is the 
need for a high concentration of the investigated factor 
(105–107 cells/ml for analysis of whole cells), development of 
spectral analysis databases for each factor, and the possibility 
of losing specificity in mixed samples. The specificity of the 
method can be increased by flow fractionation, involving the 
separation of the particles in the mixture prior to analysis 
by MALDI-TOF /mass spectrometry [113].
EIS-FTICR – Electrospray Ionization Fourier Transform Ion 
Cyclotron Resonance mass spectrometry has been used for 
simultaneous analysis of alleles of variable number tandem 
repeats, and in studies on single nucleotide polymorphism 
[114]. In this method, DNA is amplified and the size of the 
amplified fragment reduced to less than 200 bp, which is 
optimal for mass spectrometry. The analysis of the PCR 
products of the variable number tandem repeats and single 
nucleotide polymorphism in Bacillus anthracis, using EIS-
FTICR-mass spectrometry gave results comparable to 
traditional gel electrophoresis. Fourier-Transform Infrared 
Spectroscopy (FT-IR) has been also used in HazMatID 360 
and HazMatID Ranger portable devices which are capable 
of identifying over 32,000 substances, e.g. white powders.
SERS – Surface-Enhanced Raman Scattering is a technique 
also under investigation in regard to its use as a method of 
identifying pathogens’ nucleic acids and toxins. Similar to 
mass spectrometry, this technique requires a comprehensive 
analysis of each factor. Two methods for detection of 
dipicolinic acid present in bacteria spores using SERS have 
been described [115, 116]. Bell et al. increased the sensitivity 
of detection of dipicolinic acid by the addition of sodium 
sulfate and thiosulfate as an internal standard, which allowed 
a quantitative analysis [115]. Zhang et al. [116] used a silver 
film on glass nanospheres to detect the dipicolinic acid 
isolated from Bacillus subtilis spores, obtaining a sensitivity 
of approximately 103 spores in 20 µl. These authors also tested 
the portable detector, whose sensitivity has been determined 
as approximately 104 spores in 20 µl. SERS technology has 
been used in the biochip platform where specific antigen-
binding antibodies have been used [117]. The obtained data 
indicate the possibility of identification of Listeria species, 
Legionella, Bacillus species spores and Cryptosporidium 
parvum and Cryptosporidium meleagridis using this biochip. 
These authors indicated that by application of SERS analysis 
it is possible to distinguish viable and dead organisms, and 
to identify specific toxins in the mixture. The optical single-
particle binding using near-infrared SERS method [118] has 
been studied to distinguish spores of two strains of Bacillus 
stearothermophilus. This method has been also successfully 
used for distinguishing seven Escherichia coli strains and 
six clinical isolates from urinary tract infections [119]. For 
diagnostic purposes, SERS and related surface-enhanced 
resonance Raman scattering (SERRS) technology were also 
used. In this case, the analyzed factor was directly labeled 
with the active substance [120], or indirectly by gold or 
silver nanoparticles bound with the SERS /SERRS-active 
components [121, 122, 123].
Another example of the use of SERS-active components 
was described in a study in which two oligonucleotides were 
detected using the new microfluidic platform, and spectra 
and detection limits for eight dye-labeled oligonucleotides 
were analyzed using SERRS [120]. Cao et al. [121] were able 
to distinguish six different DNA strands and two different 
RNA strands using a sandwich hybridization technique 
on the biochip platform, and a SERS-active dye-labeled 
nanoparticle probe, obtaining a detection sensitivity on 
the femtomolar level. Other authors [122] have detected 
rat and goat immunoglobulin G by sandwich assay, using 
antibody-coated colloidal gold nanoparticles. The possibility 
of detecting hepatitis B surface antigen using antibodies-
labeled SERS probe in sandwich assay has also been reported 
[123]. SERS/SERRS probes may potentially increase the 
specificity of the Raman scattering method and eliminate the 
need to create a spectra database for each factor. The optical 
scattering phenomenon has been used in BARDOT (Bacteria 
Rapid Detection using Optical scattering Technology) 
technology which was applied for classification of bacteria 
belonging to Salmonella spp. [124].
Among other up-to-date diagnostic technologies one 
should also mention Interferometric Reflectance Imaging 
Sensor (IRIS) used for the detection of the H1N1 virus [125]; 
immunomagnetic biosensors [126]; microphysiometric 
devices based on electrokinetics, which are used for detection 
of cells and bacteria [127]; MBA (BioThreat Multiplex 
Assay) microfluidic system for the detection of Bacillus 
anthracis, Yersinia pestis, Francisella tularensis, Burkholderia 
pseudomallei, Burkholderia mallei and Variola major [128]; as 
well as Si technology based on microinductive devices [129]. 
A combination of protein screen and pH screen technology 
has been used in a BioCheck Powder Screening Test Kit 
based on identification of all protein containing powders. 
This kit enables a simultaneous detection of multiple possible 
biological threat agents, particularly anthrax, ricin and 
botulinum toxin.
Diagnostic nanotechnologies. Nanobiotechnology 
involves the areas of knowledge exploring and controlling 
structures, processes and functions of biological systems 
at a nanoscale (objects less than 100 nm). Nanotechnology 
creates new possibilities of monitoring human and animal 
health, as it can be used in inventing a new generation of 
biosensors (nanobiosensors and various kinds of chips) for 
microbiological diagnostics [130].
Quantum dots are the inorganic fluorescent nanocrystals 
that have the ability to change colour by changing the size and 
composition of the crystal core. They have a wide spectrum 
of absorption and a narrow emission peak, which makes 
them ideal for using in multiplexing. Furthermore, they 
are highly photostable and have a high performance. They 
are used as labels instead of conventional fluorescent dyes 
such as fluorescein and rhodamine. They have been used, 
for example, in the detection of Escherichia coli O157: H7 
[131], Cryptosporidium and Giardia spp [132, 133], and in 
the multiplex assay for the detection of cholera toxin, ricin, 
Shiga toxin 1, and staphylococcal enterotoxin B [134]. In 
order to increase the quantum efficiency, a new method 
based on nanoparticles coated with silicone (SQDNPs) has 
been used [135].
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Several studies have described the use of nanoparticles 
for detection purposes. Zinc oxide nanostructures were 
applied in a method of Bacillus anthracis detection [136]; 
use of nanowire sensors [130, 137, 138], or biosensors 
with magnetic nanoparticles [139, 140] has been reported 
for the detection of many other biomolecules; a sensitive 
nanooscillator served for detection of many pathogens [141]; 
a rapid and sensitive nanobiodetector based on polianiline 
nanofibrils was shown to be useful for detection of yeast and 
bacterial cells [142]; biodetector of the ‘ON-OFF’ type has 
been utilized for identification of Klebsiella pneumoniae, 
Pseudomonas aeruginosa, Escherichia coli and Enterococcus 
faecalis [143]. Nanomaterials based on bioamplification 
strategy have also been used [144]. Tran et al. [145] used 
a multi-layered, polianiline nanowire carbon film (PANI-
MWCNT) polymerized on a platinum electrode (IDA) for 
the detection of Human Papilloma Virus (HPV) infection.
NIDS – Nanointeligent Detection System the for rapid detection 
and identification of various biological agents (toxins, bacteria, 
spores and viruses) in various complex samples has been 
developed [146]. For rapid distinction between Gram-positive 
and Gram-negative bacteria a porous silicon nanodetector 
has been developed [147], in which micropores are coated 
with silicone antibodies against the receptor for lipid A, and 
bound Gram-negative bacteria show red photoluminescence. 
Other authors [148] studied the possibility of using bioassay 
based on bioconjugates of nanoparticles for quantitative 
analysis of pathogens in situ. Bioconjugates of nanoparticles 
provide extremely high fluorescence signal and can be easily 
incorporated with other molecules, such as antibodies. 
Nanoparticles conjugated with antibodies can specifically 
identify a broad spectrum of bacteria, such as Escherichia coli 
O157: H7 by the interaction of antigen with antibody, which 
enables to obtain a sensitivity of 1 – 400 Escherichia coli O157 
cells in contaminated beef samples. These results indicate 
a possible widespread use of nanoparticle bioconjugates in 
many biodetection systems that will be developed for the 
purposes of biotechnology and medicine. The incorporation 
of bionanotechnology into the complex biological systems 
will be a revolutionary tool for ultrasensitive detection of 
virulence markers and infectious agents.
Integrated detection systems. In recent years, integrated 
detection systems have been developed on a wide scale. 
APDS – Autonomous Pathogen Detection System is designed 
to provide civilians with an early warning in the event of a 
terrorist attack. The final APDS will be completely automated, 
offering aerosol sampling, in-line sample preparation fluidics, 
multiplexed detection and identification immunoassays, and 
orthogonal, multiplexed PCR (nucleic acid) amplification 
and detection. APDS has been used to detect, e.g. Bacillus 
globigii, Erwinia herbicola, MS2 and albumin individually, or 
in a mixture, as well as for simultaneous detection of Bacillus 
anthracis and Yersinia pestis in the air [149].
Idaho Technology Inc., a company that originated from 
the University of Utah in the USA, launched in recent years 
various innovating instruments for laboratory and field 
analysis of biological warfare agents.
RAPID and RAZOR, molecular PCR-based analyzers, are 
especially well-known types of equipment in the CBRN 
community. Recently, Idaho Technology has presented 
a Film Array technology which combines self-contained 
automatic nucleic acid isolation and its amplification. The 
entire procedure is carried out in a special apparatus which 
is equipped with two Peltier devices, LED and digital camera 
for fluorometric signal excitation and measurement, as well 
magnetic elements for analytes separation and pneumatic 
pumps for their movement through punch channels. The entire 
reaction is processed in a small self-contained macro-fluidic 
film array punch, which protects against cross-contamination 
and significantly reduces manual operation. Ceramic beads 
beating method and paramagnetic beads are applied for nucleic 
acid release and its subsequent isolation. It may deal with and 
isolate both RNA and DNA, which allows the inclusion of 
important RNA viruses into the panel of detected agents. In 
the case of RNA, cDNA is synthesized via reverse transcriptase 
reaction. Amplification and analysis steps constitute the most 
interesting part of the procedure. They comprise a two step 
PCR, which resembles the well-known nested PCR reaction. 
In this case, there is a massive (with dozens of primers) first 
step PCR, which results in first stage products. Subsequently, 
there is a specific second step which takes place in one of 96 
or 120 dots, where primers for specific agents are pre-spotted 
and freeze-dried. This physical separation of single second 
step reaction, reduces many disadvantages and complications 
related to traditional one-tube multiplex PCR assay. The second 
stage PCR is a type of real-time PCR assay with fluorescent dye 
for monitoring of amplified product number. After reaction, 
melting curve analysis is carried out for final confirmation of 
the amplified product [150].
Currently, only a panel for the detection of respiratory 
viruses is available (about 15 viral agents), but others are 
also being developed: BWA panel (17 agents, 29 molecular 
target), gastro-intestinal panel (25 agent including bacteria, 
viruses and protozoa) and blood culture ID panel (29 targets 
including bacteria (G+/G), fungi and antibiotic resistance 
genes). The advantages of this ‘lab-on-chip’ system, such as 
the multiplexing capability or increased overall sensitivity 
of the assay, promote this instrument to be used in field 
laboratory conditions or point-of-care scenarios. The only 
limitation of this technology is its low throughput: one 
sample per 60 min is not a significant result when compared 
with other competing detection systems [150].
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